Core Insights - HP is expected to report quarterly earnings of $0.92 per share, reflecting a decline of 1.1% year-over-year, while revenues are forecasted to reach $15.02 billion, indicating a 6.9% increase compared to the previous year [1] - The consensus EPS estimate has been revised downward by 1.3% in the last 30 days, showing a reassessment by analysts [1][2] Revenue Projections - Analysts project 'Net revenue- Personal Systems- Commercial PS' to be $7.34 billion, a year-over-year increase of 12.5% [4] - The estimated 'Net revenue- Personal Systems- Consumer PS' is $3.38 billion, reflecting a 10.1% increase year-over-year [4] - Total 'Net revenue- Personal Systems' is expected to reach $10.72 billion, indicating an 11.8% increase from the prior year [4] - 'Net revenue- Printing- Supplies' is projected at $2.81 billion, showing a decline of 2% year-over-year [5] - 'Net revenue- Printing- Commercial Printing' is estimated at $1.18 billion, reflecting a 6.1% decrease [5] - 'Net revenue- Printing- Consumer Printing' is forecasted at $302.61 million, indicating a 6.9% decline [6] - Overall 'Net revenue- Printing' is expected to be $4.29 billion, a decrease of 3.5% from the previous year [6] Operational Metrics - 'Days in accounts payable' is estimated to be 137 days, slightly down from 138 days in the previous year [6] - 'Days of sales outstanding in accounts receivable' is projected at 32 days, compared to 33 days reported last year [7] - 'Days of supply in inventory' is expected to reach 67 days, up from 63 days in the same quarter last year [7] Earnings from Operations - 'Earnings from operations- Personal Systems' is projected at $632.41 million, an increase from $550.00 million reported last year [8] - 'Earnings from operations- Printing' is expected to be $798.79 million, down from $874.00 million in the previous year [8] Stock Performance - Over the past month, HP shares have declined by 18.8%, contrasting with a -0.3% change in the Zacks S&P 500 composite [8]

Core Insights - The upcoming earnings report for Gap (GAP) is projected to show a quarterly earnings of $0.58 per share, reflecting a decline of 19.4% year-over-year, while revenues are expected to reach $3.91 billion, indicating a 2.2% increase compared to the previous year [1] Earnings Estimates - There has been a 1.7% upward revision in the consensus EPS estimate over the last 30 days, indicating analysts' reassessment of their initial forecasts [2] - Revisions to earnings projections are crucial for predicting investor behavior and are strongly correlated with short-term stock price performance [3] Revenue and Sales Projections - Analysts forecast 'Net Sales- Gap Global- Total' at $930.22 million, a year-over-year increase of 3.5% [5] - 'Net Sales- Banana Republic Global- Total' is expected to reach $478.26 million, reflecting a 2% increase year-over-year [5] - 'Net Sales- Old Navy Global- Total' is projected at $2.21 billion, indicating a 3% year-over-year change [5] Store Locations and Comparable Sales - The estimated 'Number of Store Locations - Banana Republic - Total' is 410, down from 433 year-over-year [6] - The consensus for 'Number of Store Locations - Old Navy North America' is 1,241, compared to 1,255 last year [6] - Analysts expect 'Comparable Store Sales - Gap - YoY change' to be 4.3%, up from 3.0% year-over-year [7] Square Footage Estimates - The total 'Square Footage - Gap North America' is estimated at 5 million square feet, unchanged from the previous year [9] - 'Square Footage - Old Navy North America' is also projected to remain at 20 million square feet, consistent with last year's figure [9] Stock Performance - Over the past month, Gap shares have increased by 11.8%, outperforming the Zacks S&P 500 composite, which rose by 1.5% [10] - Currently, Gap holds a Zacks Rank 3 (Hold), suggesting its performance may align with the overall market in the near future [10]

Core Insights - Medtronic (MDT) is expected to report quarterly earnings of $1.31 per share, a 4% increase year-over-year, with revenues projected at $8.86 billion, reflecting a 5.4% increase from the previous year [1] Earnings Estimates - The consensus EPS estimate has been revised down by 0.1% in the last 30 days, indicating a reassessment by analysts [2] - Changes in earnings estimates are crucial for predicting investor reactions, as empirical studies show a strong correlation between earnings estimate revisions and short-term stock performance [3] Revenue Projections - Analysts project 'Net Sales- World Wide Revenue- Diabetes' at $749.45 million, a 9.3% increase year-over-year [5] - 'Net Sales- World Wide Revenue- Neuroscience' is expected to reach $2.49 billion, reflecting a 1.5% increase from the prior year [5] - 'Net Sales- World Wide Revenue- Cardiovascular' is forecasted at $3.36 billion, indicating an 8.5% increase year-over-year [6] - 'Net Sales- World Wide Revenue- Medical Surgical' is anticipated to be $2.24 billion, a 5.4% increase from the previous year [6] - 'Net Sales- U.S. Revenue' is projected at $4.53 billion, reflecting a 5.3% increase year-over-year [6] Specific Segment Estimates - 'Net Sales- U.S. Revenue- Medical Surgical' is expected to be $938.99 million, showing a slight decline of 0.5% year-over-year [7] - 'Net Sales- U.S. Revenue- Neuroscience- Neuromodulation' is projected at $351.65 million, a 5.6% increase from the prior year [7] - 'Net Sales- ROW- Neuroscience- Cranial & Spinal Technologies' is estimated at $326.68 million, indicating a 6.1% increase year-over-year [7] - 'Net Sales- ROW- Neuroscience- Specialty Therapies' is expected to be $319.41 million, reflecting a minimal change of +0.1% year-over-year [8] - 'Net Sales- ROW- Medical Surgical- Surgical & Endoscopy' is projected at $1.03 billion, indicating a 5.4% increase year-over-year [9] - 'Net Sales- ROW- Cardiovascular' is expected to reach $1.80 billion, reflecting a 7.8% increase from the prior year [9] Stock Performance - Over the past month, Medtronic shares have returned +0.5%, compared to the Zacks S&P 500 composite's +4.6% change, suggesting that MDT is likely to perform in line with the overall market [9]

Core Insights - Chevron reported a revenue of $49.73 billion for the quarter ended September 2025, reflecting a decrease of 1.9% year-over-year and falling short of the Zacks Consensus Estimate of $53.58 billion by 7.19% [1] - The company's EPS was $1.85, down from $2.51 in the same quarter last year, but exceeded the consensus estimate of $1.66 by 11.45% [1] Financial Performance Metrics - Total net oil-equivalent production reached 4,086 million barrels, surpassing the average analyst estimate of 3,927.88 million barrels [4] - U.S. upstream net oil-equivalent production per day was 2,040 million barrels, exceeding the analyst estimate of 1,950.41 million barrels [4] - International upstream net oil-equivalent production per day was 2,046 million barrels, above the average estimate of 1,977.47 million barrels [4] - U.S. upstream revenue from natural gas realization was $1.77 per thousand cubic feet, higher than the estimated $1.65 [4] - U.S. upstream net natural gas production per day was 3,265 Mcf/D, exceeding the estimate of 3,094.04 Mcf/D [4] - Worldwide net natural gas production per day was 8,939 Mcf/D, above the estimate of 8,593.22 Mcf/D [4] - Worldwide net crude oil and natural gas liquids production per day was 2,595 million barrels, surpassing the estimate of 2,508.3 million barrels [4] - U.S. upstream net crude oil and natural gas liquids production per day was 1,496 million barrels, exceeding the estimate of 1,437.54 million barrels [4] - International upstream net natural gas production per day was 5,674 Mcf/D, above the estimate of 5,499.18 Mcf/D [4] Revenue Breakdown - Other income was reported at $576 million, significantly higher than the estimated $263.75 million, representing a year-over-year increase of 19.5% [4] - Income from equity affiliates was $981 million, compared to the average estimate of $388.79 million, showing a year-over-year decline of 22.2% [4] - Sales and other operating revenues were $48.17 billion, below the average estimate of $50.13 billion, reflecting a year-over-year decrease of 1.6% [4] Stock Performance - Chevron's shares returned +0.9% over the past month, while the Zacks S&P 500 composite experienced a -0.2% change [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance relative to the broader market in the near term [3]

Core Insights - American Healthcare REIT (AHR) reported revenue of $572.94 million for Q3 2025, a 9.4% increase year-over-year, with an EPS of $0.44 compared to -$0.03 a year ago [1] - The revenue exceeded the Zacks Consensus Estimate of $565.26 million by 1.36%, and the EPS also surpassed the consensus estimate of $0.42 by 4.76% [1] Revenue Breakdown - Resident fees and services generated $532.06 million, slightly below the two-analyst average estimate of $535.68 million, reflecting an 11.6% year-over-year increase [4] - Real estate revenue was reported at $40.88 million, exceeding the average estimate of $39.47 million, but showing a 13% decline year-over-year [4] Stock Performance - Over the past month, shares of American Healthcare REIT have returned +17.2%, significantly outperforming the Zacks S&P 500 composite's +1.3% change [3] - The stock currently holds a Zacks Rank 2 (Buy), indicating potential for outperformance in the near term [3]

Core Insights - Blue Owl Capital Corporation reported $453.07 million in revenue for Q3 2025, marking an 11.6% year-over-year increase, but fell short of the Zacks Consensus Estimate by 1.84% [1] - The company's EPS for the same quarter was $0.36, down from $0.47 a year ago, representing a surprise of -7.69% compared to the consensus estimate of $0.39 [1] Financial Performance Metrics - Investment income from non-controlled, non-affiliated investments showed a total of $403.35 million, a 9.7% increase year-over-year, but below the average estimate of $412.83 million [4] - Interest income from non-controlled, non-affiliated investments was reported at $349.05 million, reflecting a 16.5% year-over-year increase, yet it was lower than the average estimate of $356.5 million [4] - Total investment income from controlled, affiliated investments reached $48.4 million, exceeding the average estimate of $42.95 million, with a year-over-year change of 28.2% [4] - Dividend income from controlled, affiliated investments was reported at $37.92 million, surpassing the average estimate of $33.13 million, with a year-over-year increase of 28% [4] - The stock of Blue Owl Capital Corporation has returned +3% over the past month, outperforming the Zacks S&P 500 composite's +1% change [3]

Core Insights - Hub Group reported revenue of $934.5 million for the quarter ended September 2025, reflecting a year-over-year decline of 5.3% and an EPS of $0.49 compared to $0.52 a year ago, with a slight revenue surprise of +0.58% over the Zacks Consensus Estimate of $929.12 million [1] Financial Performance - Operating Revenue from Intermodal and Transportation Solutions was $561.49 million, exceeding the three-analyst average estimate of $539.45 million, with a year-over-year change of +0.3% [4] - Operating Revenue from Inter-segment eliminations was reported at $-29.39 million, slightly worse than the estimated $-28.14 million, showing a year-over-year decline of -13.4% [4] - Operating Revenue from Logistics was $402.4 million, below the average estimate of $418.62 million, representing a year-over-year decrease of -12.7% [4] Market Performance - Hub Group's shares have returned +6.5% over the past month, outperforming the Zacks S&P 500 composite's +3.6% change, although the stock currently holds a Zacks Rank 5 (Strong Sell), indicating potential underperformance in the near term [3]

Core Insights - Axos Financial reported revenue of $323.39 million for the quarter ended September 2025, reflecting a year-over-year increase of 0.9% and a surprise of +0.79% over the Zacks Consensus Estimate of $320.85 million [1] - The company's EPS for the quarter was $2.07, up from $1.96 in the same quarter last year, resulting in an EPS surprise of +11.29% compared to the consensus estimate of $1.86 [1] Financial Metrics - The efficiency ratio was reported at 48.3%, slightly above the average estimate of 47.2% based on two analysts [4] - The net interest margin stood at 4.8%, matching the average estimate from two analysts [4] - Net annualized charge-offs to average loans were 0.1%, consistent with the average estimate of 0.1% from two analysts [4] - Total non-interest income was $32.34 million, exceeding the average estimate of $32.09 million based on two analysts [4] - Net interest income was reported at $291.05 million, surpassing the average estimate of $288.73 million from two analysts [4] Stock Performance - Over the past month, shares of Axos Financial have returned -5.7%, contrasting with the Zacks S&P 500 composite's increase of +3.6% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market in the near term [3]

Core Insights - Beacon Financial reported revenue of $144.95 million for the quarter ended September 2025, reflecting a year-over-year increase of 32.3% [1] - The company's EPS was $0.44, down from $0.58 in the same quarter last year, indicating a significant decline [1] - Revenue exceeded the Zacks Consensus Estimate of $144.1 million by 0.59%, while the EPS fell short of the consensus estimate of $0.85 by 48.24% [1] Financial Performance Metrics - Total earning assets averaged $14.23 billion, surpassing the estimated $12.87 billion [4] - The net interest margin was reported at 3.7%, exceeding the average estimate of 3.2% [4] - Total non-interest income was $12.35 million, significantly below the average estimate of $20.63 million [4] - Net interest income reached $132.61 million, compared to the estimated $90.84 million [4] Stock Performance - Over the past month, Beacon's shares returned +0.8%, while the Zacks S&P 500 composite increased by +3.8% [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]

Core Insights - Element Solutions (ESI) reported revenue of $656.1 million for Q3 2025, marking a year-over-year increase of 1.7% and exceeding the Zacks Consensus Estimate by 1.51% [1] - The earnings per share (EPS) for the quarter was $0.41, up from $0.39 a year ago, representing a surprise of 5.13% over the consensus estimate [1] Financial Performance Metrics - Net Sales in the Industrial & Specialty segment were $190.9 million, slightly above the average estimate of $189.5 million, but reflecting a year-over-year decline of 15.5% [4] - Net Sales in the Electronics segment reached $465.2 million, surpassing the average estimate of $456.85 million, with a year-over-year increase of 11% [4] - Adjusted EBITDA for the Industrial & Specialty segment was $45.4 million, exceeding the estimated $40.45 million [4] - Adjusted EBITDA for the Electronics segment was $101.5 million, slightly below the estimated $103.15 million [4] Stock Performance - Over the past month, shares of Element Solutions have returned +6%, outperforming the Zacks S&P 500 composite's +3.6% change [3] - The stock currently holds a Zacks Rank 2 (Buy), indicating potential for outperformance in the near term [3]